BridgeMD
New treatment option for Gynecologic Cancer
Official title Study Looking at Biomarkers in Ovarian Cancer
ClinicalTrials.gov ID: NCT03419689
What this study is testing
- What it's testing
- This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
You likely can't join if
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
See the full eligibility criteria
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
- Willing to undergo blood or fluid collection and tumour biopsy
- Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
- Archival tissue must be available for patients that are enrolled at the time of progression.
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
The study team makes the final eligibility decision.
Where it's taking place
- Barrie, Ontario, Canada
- Hamilton, Ontario, Canada
- Kingston, Ontario, Canada
- London, Ontario, Canada
- Ottawa, Ontario, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barrie, Ontario, Canada; Hamilton, Ontario, Canada; Kingston, Ontario, Canada; London, Ontario, Canada; Ottawa, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.